Body mass index

Lore & Background

Adolphe Quetelet, a Belgian astronomer, mathematician, statistician, and sociologist, devised the basis of the BMI between 1830 and 1850 as he developed what he called 'social physics.' Quetelet never intended the index, then called the Quetelet Index, to be used for medical assessment; instead, it was a component of his study of l'homme moyen, or the average man. He thought of the average man as a social ideal and developed the BMI as a means of discovering the socially ideal human person. According to Lars Grue and Arvid Heiberg, Quetelet's idealization of the average man would later be elaborated upon by Francis Galton in the development of eugenics.

The modern term 'body mass index' was coined in a paper published in the July 1972 edition of the Journal of Chronic Diseases by Ancel Keys and others. In that paper, Keys argued that what he termed the BMI was 'if not fully satisfactory, at least as good as any other relative weight index as an indicator of relative obesity.' Keys explicitly judged BMI as appropriate for population studies and inappropriate for individual evaluation, a distinction that continues to be cited as a limitation.

The interest in an index that measures body fat came with observed increasing obesity in prosperous Western societies. Despite its limitations, due to its simplicity, BMI has come to be widely used for preliminary diagnoses. Additional metrics, such as waist circumference, can be more useful.

Reader's Guide

The body mass index remains a widely used screening tool for categorizing weight status in populations, though its limitations for individual assessment are well documented. Quetelet's original concept, intended to describe the average man rather than diagnose health, was repurposed by later researchers. The index's simplicity—requiring only weight and height—has ensured its continued use in clinical and public health settings, despite the fact that individuals with the same BMI can differ substantially in body composition and fat distribution. BMI values under 20 and over 25 have been associated with higher all-cause mortality, with risk increasing further from that interval. The WHO and various national health bodies have established cut-off points for underweight, normal weight, overweight, and obesity, though these thresholds vary by population, particularly for Asian groups who may face higher health risks at lower BMIs. The index is also used differently for children and youth, where it is compared against percentiles for the same sex and age rather than fixed thresholds. While BMI provides a useful statistical measure for groups, its application to individuals—especially lean athletes, those with abdominal obesity, or short stature—requires caution and often supplementation with other metrics.

Did You Know?

• Adolphe Quetelet devised the basis of the BMI between 1830 and 1850 as part of his study of 'l'homme moyen,' or the average man.
• The modern term 'body mass index' was coined by Ancel Keys and others in a 1972 paper in the Journal of Chronic Diseases.
• BMI values under 20 and over 25 have been associated with higher all-cause mortality, with risk increasing with distance from the 20–25 interval.
• The BMI is calculated as mass in kilograms divided by the square of height in metres, and when using pounds and inches, a conversion factor of 703 is applied.

The Ellipse Model: A Geometric Reimagining

BRI was introduced in 2013 by mathematician Diana Thomas and her team, who challenged the cylindrical body model underlying traditional metrics. Instead of treating the human form as a simple tube, they visualized body shape as an egg or ellipse, capturing the degree of roundness through the mathematical concept of eccentricity. In this framework, a perfect circle—where waist circumference equals height—yields an eccentricity of zero, while a perfectly vertical line reaches one. To make the numbers more intuitive for clinical use, Thomas and colleagues remapped that 0-to-1 scale onto a 1-to-20 range using the equation BRI = 364.2 − 365.5 × Eccentricity. The resulting index is essentially a reformulation of the waist-to-height ratio, requiring only a tape measure to record waist circumference and height in any consistent unit. This geometric approach gives BRI its distinctive character: rather than weighing a person against their stature, it measures how round or narrow the midsection appears relative to overall height, offering a visual and anthropometric lens for evaluating body composition.

Where BRI Outperforms Traditional Metrics

One of the most persistent criticisms of BMI is its inability to separate lean muscle from adipose tissue, meaning a muscular athlete and a sedentary person with the same weight-to-height ratio receive identical classifications. BRI sidesteps this problem by quantifying body girth alongside height, which allows it to more accurately estimate both total body fat and the volume of visceral adipose tissue. In a head-to-head comparison involving BMI, body shape index, conicity index, body adiposity index, waist-to-hip ratio, and abdominal volume index, BRI and AVI emerged as the most effective predictors of nonalcoholic fatty liver disease risk. They also successfully stratified NAFLD diagnoses across race, age, and gender. Furthermore, in Chinese women, BRI outperformed both BMI and body shape index when forecasting the likelihood of hypertension, dyslipidemia, and hyperuricemia. These findings suggest that capturing the geometric roundness of the torso provides a more nuanced picture of metabolic health than weight alone can deliver.

Reading the Numbers: What BRI Scores Tell Us About Risk

BRI values observed in the U.S. National Health and Nutrition Examination Survey database span from 1 to 16, with the majority of adults clustering between 1 and 10. A score of 3 or below generally reflects a lean midsection, while 7 or above signals noticeable roundness; the midpoint sits around 5. The health implications of crossing certain thresholds are striking. Individuals scoring 6.9 or higher—indicating wider, rounder bodies—faced an all-cause mortality risk elevated by as much as 49 percent compared with those at the medium value of 5. A 2020 review reinforced these concerns, linking high BRI to increased susceptibility to metabolic syndrome and a cluster of other diseases. Clinical research has also demonstrated that BRI serves as an effective identifier for death risk across multiple conditions, including liver disease, cardiovascular complications associated with sarcopenia, and bone mineral density issues. The spectrum extends from lean individuals below 3 to severely obese individuals above 12, though the authors caution that adjacent categories can overlap, blurring the boundaries between health classifications.

Growing Pains: Limitations and the Road Ahead

Despite its promising early results, BRI remains a relatively young metric with a considerably smaller research footprint than long-standing indices such as BMI or the waist-to-hip ratio. Its accuracy and full range of clinical applications have yet to be as thoroughly validated through longitudinal studies. In some countries, the simpler waist-to-height ratio—which uses the same two measurements but is easier to compute—has been adopted as the preferred guideline precisely because of its more extensive evidence base. Practical measurement challenges also persist: in standing obese individuals, waist and hip circumference readings can vary significantly, and that variability may reflect genuine differences in visceral fat distribution, introducing error into the BRI calculation. Additionally, the index does not incorporate important diagnostic context such as ethnicity, family history, dietary patterns, or physical activity levels, nor does it account for outcomes like organ health status or disease duration. Until further research closes these gaps, BRI is best understood as a complementary tool rather than a definitive replacement for established anthropometric measures.